NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹71 Cr | ₹85 Cr | ₹96 Cr | ₹100 Cr | ₹90 Cr |
What is the latest Long Term Provisions ratio of NATCO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹71 Cr |
Mar2023 | ₹85 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹100 Cr |
Mar2020 | ₹90 Cr |
How is Long Term Provisions of NATCO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹71 Cr | -16.88 | |
Mar2023 | ₹85 Cr | -10.87 | |
Mar2022 | ₹96 Cr | -3.92 | |
Mar2021 | ₹100 Cr | 10.42 | |
Mar2020 | ₹90 Cr | - |
Compare Long Term Provisions of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,136.6 Cr | 2.2% | 2.4% | -15.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹429,217.0 Cr | 5.7% | 3.2% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,100.0 Cr | 2.8% | 1.7% | 59.1% | Stock Analytics | |
CIPLA | ₹123,856.0 Cr | 2.5% | 2.3% | 13.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,850.0 Cr | 3.5% | 4.4% | 27.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,962.2 Cr | 2.3% | 1.2% | -1.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 2.2% |
2.4% |
-15.6% |
SENSEX | 4.4% |
6.4% |
9.8% |
You may also like the below Video Courses